首 页
医药产品
医保药品
中标目录
医药招标
数据中心
医学资料
医药新闻
医药展会
OTC药品
保健品
医疗器械
处方药
专科药
中医药
器械中标目录
药品批发行情
求购信息
医药下载
药价简讯
当前位置:药药网 / 数据中心 /生物制药海外临床研究状况
标题:
分类:
生物制药海外临床研究状况
生物制药海外授权产品
生物制药许可证管理文件
生物制药海外临床研究状况11754个记录
生物制药海外临床研究状况
序号
标题(英文)
分类
141
NT-I7 for the Treatment of Recurrent Squamous Cell Carcinoma of Head and Neck Undergoing Surgery
基因重组药物
142
A Study of Sintilimab Plus Ramucirumab as First-line Treatment for G/EGJ Adenocarcinoma (ORIENT-106)
抗体
143
Phase Ib Study of the Safety of T-DXd and Durvalumab With Chemotherapy in Advanced or Metastatic HER2+ Non-squamous NSCLC
抗体
144
Phase Ib Study of the Safety of T-DXd and Durvalumab With Chemotherapy in Advanced or Metastatic HER2+ Non-squamous NSCLC
抗体
145
Phase Ib Study of the Safety of T-DXd and Durvalumab With Chemotherapy in Advanced or Metastatic HER2+ Non-squamous NSCLC
抗体
146
Phase Ib Study of the Safety of T-DXd and Durvalumab With Chemotherapy in Advanced or Metastatic HER2+ Non-squamous NSCLC
抗体
147
Phase Ib Study of the Safety of T-DXd and Durvalumab With Chemotherapy in Advanced or Metastatic HER2+ Non-squamous NSCLC
抗体
148
Phase Ib Study of the Safety of T-DXd and Durvalumab With Chemotherapy in Advanced or Metastatic HER2+ Non-squamous NSCLC
抗体
149
Phase Ib Study of the Safety of T-DXd and Durvalumab With Chemotherapy in Advanced or Metastatic HER2+ Non-squamous NSCLC
抗体
150
Thrombosomes® in Bleeding Thrombocytopenic Patients Study
血液制品|血浆馏分制品
151
Convection-enhanced Delivery of OS2966 for Patients With High-grade Glioma Undergoing a Surgical Resection
抗体
152
A Controlled Phase 2/3 Study of Adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Vaccine (SCB-2019) for the Prevention of COVID-19
疫苗
153
A Controlled Phase 2/3 Study of Adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Vaccine (SCB-2019) for the Prevention of COVID-19
疫苗
154
A Controlled Phase 2/3 Study of Adjuvanted Recombinant SARS-CoV-2 Trimeric S-protein Vaccine (SCB-2019) for the Prevention of COVID-19
疫苗
155
Safety Study of PTP-001 for Treating Knee Osteoarthritis
细胞疗法
156
Safety and Immunogenicity of AdCOVID in Healthy Adults (COVID-19 Vaccine Study)
疫苗
157
Obinutuzumab, Ibrutinib, and Venetoclax for the Treatment of Previously Untreated Stage II-IV Follicular Lymphoma
抗体
158
A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer
抗体
159
A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer
抗体
160
A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer
抗体
首页
(current)
4
(current)
5
(current)
6
(current)
7
(current)
8
(current)
9
(current)
10
(current)
11
(current)
12
(current)
13
(current)
(current)
末页
(current)
最新招商产品
更多>>
谱能,亚胺培南西司他丁钠:百福特药业
间苯三酚:百福特药业
依达拉奉注射液:百福特药业
保胎灵:石家庄百福特药业有限公司
罗汀(泛昔洛韦片):石家庄百福特药业有限..
血塞通:石家庄百福特药业有限公司
复方骨肽:石家庄百福特药业有限公司
注射用法莫替丁:石家庄百福特药业有限公司..
邦亭(注射用白眉蛇毒血凝酶):石家庄百福..
绵舒 (注射用鹿瓜多肽):石家庄百福特药..
奥拉西坦注射液:石家庄百福特药业有限公司..
单唾液酸四己糖神经节苷脂钠:石家庄百福特..
烟酰胺注射液:石家庄百福特药业有限公司
益生菌 医伍柒益生菌:石家庄百福特..
头孢地尼分散片:安徽柯斯达
头孢丙烯干混悬剂:安徽柯斯达
头孢地尼分散片,头孢丙烯干混悬剂等:柯斯..
0.6蒲地蓝消炎片:湖南时代精英
苯磺酸氨氯地平片:湖南时代精英
:
头孢呋辛酯干混悬剂:安徽柯斯达医药
远红外止咳贴:楚德药业
司韵:宫颈凝胶
内窥镜穿刺气腹针:武汉众福
内窥镜手术穿刺器:武汉众福
手术切口保护套:武汉众福
一次性使用内窥镜标本取物袋:武汉众福
一次性微创筋膜吻合器:武汉众福
婴儿脐带贴:武汉众福
钕铁硼永磁贴:武汉众福
网站地图
-
网站开发
-
网站简介
-
会员服务
-
法律声明
-
联系我们
-
药品招商频道
-
药品信息排行
-
2018年版国家基本药物目录
-
意见反馈
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:
国家药品监督管理局
|
国家中医药管理局
|
SDA药品评审中心
|
医加医疗器械
|
膏药生产厂家
|
爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究 客服热线:0575-83552251 / 13754370441 QQ客服:
浙ICP备16010490号-2
增值电信业务经营许可证:
浙B2-20220931
互联网药品信息服务资格证书编号:
(浙)-经营性2023-0215
浙公网安备:33068302000535
医药代理商群1:
医药代理商群2:
医药代理商群3: